Alnylam Pharmaceuticals
ALNY
#459
Rank
โ‚น4.745 T
Marketcap
โ‚น35,920
Share price
-0.28%
Change (1 day)
61.37%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company